ShareHub

Stock Market Today, March 30: Tesla Slides on EV Pricing Pressure as Investors Await Q1 2026 Delivery Data | The Motley Fool

Today, March 30, 2026, investors are weighing EV price cuts against an ambitious AI and robotaxi pivot shaping this market story.

Stock Market Today, March 30: Microsoft Rises on Copilot Expansion and New AI Product Launches | The Motley Fool

Microsoft rose as Copilot rollout and enterprise demand drive AI growth, with focus turning to how quickly that momentum can translate into revenue without a...

Stock Market Today, March 30: High Oil Prices Drive Risk-Off Sentiment, Nasdaq Falls 0.7% | The Motley Fool

Inflation and growth worries impacted tech stocks as investors question AI price tags today, March 30, 2026.

Gulf Prtroleum Chief Lawyer's Holdings Have Shrunk 91% — Now He's Helping Run the Company | The Motley Fool

Operating in the Utica Shale and SCOOP regions, this energy producer reported a notable insider sale amid ongoing portfolio adjustments.

Stock Market Today, March 30: Fermi Shares Plunge After Wider Loss and No Tenant for Flagship AI Project | The Motley Fool

Fermi’s widening losses, tenant delays, and new financing are redefining the AI data-center risk profile, today, March 30, 2026.

Today, March 30, 2026, investors send Boston Scientific shares lower as they dig deeper into the company's latest trial update.

This specialty pharma firm focused on pain management therapies reported a notable insider sale amid steady revenue and recent stock gains.

These three software giants have all taken a hit this year, but only one looks like a buy.

Stock Market Today, March 30: Micron Technology Falls on TurboQuant Shock | The Motley Fool

Today, March 30, 2026, investors are weighing record AI-fueled growth against a new, memory-efficient algorithm.

IREN fell as its AI data center push raises capital needs, with focus on how quickly it can grow beyond Bitcoin without increasing dilution.

This biotech innovator in cystic fibrosis therapies reported a notable insider sale, as disclosed in recent SEC filings.

Ligand Pharmaceuticals, a leader in drug licensing and royalties, reported a notable insider sale amid strong recent share performance.

Adaptive Biotechnologies, a leader in immune-driven diagnostics, reported a notable insider sale amid strong one-year stock gains.